DrugRepV_6981 | 3-azido-2,3-dideoxyuridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6982 | 1-(4-azido-5-hydroxyoxolan-2-yl)-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6983 | 1-(4-azido-5-hydroxyoxolan-2-yl)-5-(trifluoromethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6984 | 2- deoxy-5-fluorouridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6985 | 2- deoxy-5-bromouridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6986 | 2-deoxy-5-iodouridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6987 | 3-Azido-2,3-dideoxy-5-aminouridine Hydrochloride | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6988 | 3-Azido-2,3-dideoxy-5-(methylamino)uridine hydrochloride | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6989 | 3-Azido-2,3-dideoxy-5-(dimethylamino)uridine hydrochloride | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6990 | 3-Azido-2,3-dideoxy-5-hydroxyuridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6991 | 3-Azido-2,3-dideoxy-5-methoxyuridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6992 | 3-Azido-2,3-dideoxy-5-ethoxyuridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6993 | 3-Azido-2,3-dideoxy-5-(2-propynyloxy)uridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6994 | 3-Azido-2,3-dideoxy-5-(propenyloxy)uridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6995 | 3-Azido-2,3-dideoxy-5-[(cyanomethyl)oxy]uridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6996 | 3-Azido-2,3-dideoxy-5-thiocyanatouridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6997 | 3-Azido-2,3-dideoxy-5-(methylthio)uridine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6998 | 2-deoxycytidine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_6999 | 2-deoxy-5-fluorocytidine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_7000 | 2,-deoxy-5-methylcytidine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_7001 | 3-(3-Oxo-l-propenyI)-3-azido-3-deoxyThymidine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |
DrugRepV_7002 | 3-Azido-3-deoxy-6-azaThymidine | NA | NA | Human immunodeficiency virus | LAV | | RT assay | Decrease (50 %) | NA | 3339606 |